BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 57231)

  • 1. Iodinated bleomycin: an unsatisfactory radiopharmaceutical for tumor localization.
    Eckelman WC; Kubota H; Siegel BA; Komai T; Rzeszotarski WJ; Reba RC
    J Nucl Med; 1976 May; 17(5):385-8. PubMed ID: 57231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of radiolabeled bleomycins and gallium citrate in tumor-bearing mice.
    Krohn KA; Meyers JM; DeNardo GL; DeNardo SJ
    J Nucl Med; 1977 Mar; 18(3):276-81. PubMed ID: 65460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and biologic properties of isolated radiolabeled bleomycin preparations.
    Eckelman WC; Rzeszotarski WJ; Siegel BA; Kubota H; Chelliah M; Stevenson J; Rebra RC
    J Nucl Med; 1975 Nov; 16(11):1033-7. PubMed ID: 52699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cobalt-labeled bleomycin--a new radiopharmaceutical for tumor localization. A comparative clinical evaluation with gallium citrate.
    Poulose KP; Watkins AE; Reba RC; Eckelman WC; Goodyear M
    J Nucl Med; 1975 Sep; 16(9):839-41. PubMed ID: 51080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Contribution to the scintigraphic diagnosis of malignant endothoracic tumors by 57Co labeled Bleomycin (author's transl)].
    Lucot H; Blasco A; Bollinelli R; Boneu A; Bru A; Combes PF; Vigoni A
    J Radiol Electrol Med Nucl; 1976 Jan; 57(1):69-78. PubMed ID: 56439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of radio-labelled bleomycin for tumor detection.
    Rasker JJ; Beekhuis H; van de Poll MA; Versluis A; Jurjens H; Woldring MG
    Nuklearmedizin; 1978 Dec; 17(6):238-48. PubMed ID: 84374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Distribution study using 57Co-, 51Cr-, 111In- and 99mTc-bleomycin in mice with a solid Ehrlich carcinoma].
    Zimmermann M; Hale T
    Nuklearmedizin; 1976 Aug; 15(4):176-82. PubMed ID: 62345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labelling of bleomycin with cobalt-57, indium-111, technetium-99m, mercury-197, lead-203, and copper-67.
    van de Poll MA; Versluis A; Rasker JJ; Jurjens H; Woldring MG
    Nuklearmedizin; 1976 Apr; 15(2):86-90. PubMed ID: 58409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluation of radiolabeled bleomycin (BLEO) for tumor detection.
    Grove RB; Reba RC; Eckelman WC; Goodyear M
    J Nucl Med; 1974 Jun; 15(6):386-90. PubMed ID: 4133503
    [No Abstract]   [Full Text] [Related]  

  • 10. [Positive tumor scintigraphy. I. Pharmacokinetics of 111In and 57Co bleomycin].
    Blottner A; Deckart H; Weiland J
    Radiobiol Radiother (Berl); 1978 Jun; 19(3):365-77. PubMed ID: 82976
    [No Abstract]   [Full Text] [Related]  

  • 11. Relative tissue distribution of radioactivity in rats with endocrine "autonomous" breast carcinomas after 3H-,99mTc-, and 64Cu-bleomycin.
    Ryo UY; Ice RD; Jones JD; Beierwaltes WH
    J Nucl Med; 1975 Feb; 16(2):127-31. PubMed ID: 45938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The place of 57Co-bleomycin scanning in the evaluation of tumors.
    Kahn PC; Milunsky C; Dewanjee MK; Rudders RA
    AJR Am J Roentgenol; 1977 Aug; 129(2):267-73. PubMed ID: 70990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of dose loading and of double labelling with 57Co and 125I on the tissue distribution in animals.
    Vos CM; Westera G; van der Jagt PJ; van Zanten B
    Eur J Nucl Med; 1979 Oct; 4(5):393-6. PubMed ID: 93048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some experience with 57Co-labeled bleomycin as a tumor-seeking agent.
    Rasker JJ; Poll AM; Beekhuis H; Woldring MG; Nieweg HO
    J Nucl Med; 1975 Nov; 16(11):1058-69. PubMed ID: 52700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of liver metastases with a combination of 57Co-bleomycin and 99mTc-sulfur colloid].
    Haubold U
    Strahlentherapie Sonderb; 1975; 74():490-5. PubMed ID: 53915
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor imaging after administration of 99mTc-labeled bleomycin.
    Mori T; Hamamoto K; Onoyama Y; Torizuka K
    J Nucl Med; 1975 May; 16(5):414-22. PubMed ID: 53278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer diagnosis. The role of tumor-imaging radiopharmaceuticals.
    Silberstein EB
    Am J Med; 1976 Feb; 60(2):226-37. PubMed ID: 56131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor scintigraphy using 57Co-BLM. Comparison with 67Ga-citrate].
    Sasaki K; Umayahara A; Shimoda Y; Tanoue S
    Rinsho Hoshasen; 1976 Apr; 21(5):405-11. PubMed ID: 61296
    [No Abstract]   [Full Text] [Related]  

  • 19. [Tumor affinity and DNA interactions of 57Co-bleomycin (author's transl)].
    Kakinuma J; Honjo Y; Orii H
    Radioisotopes; 1982 Apr; 31(4):175-8. PubMed ID: 6180460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of 111In-bleomycin and 111 In-chlorides in mice.
    Konikowski T; Haynie TP; Glenn HJ
    J Nucl Med; 1975 Aug; 16(8):738-43. PubMed ID: 51922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.